View in EDS

Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition.

Saved in:
Bibliographic Details
Title: Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition.
Authors: Wilkinson S; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Ku AT; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Lis RT; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., King IM; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Low D; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Trostel SY; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Bright JR; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Terrigino NT; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Baj A; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Summerbell ER; Office of Intramural Research, National Institutes of Health, Bethesda, Maryland, USA., Heyward KE; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Kartal S; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.; Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Fenimore JM; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Li C; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Singler C; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Vo B; Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA., Jansen CS; Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA., Ye H; Department of Pathology and Department of Urology, UCLA, Los Angeles, California, USA., Whitlock NC; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Harmon SA; Molecular Imaging Branch., Carrabba NV; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Atway R; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Lake R; Laboratory of Cancer Biology and Genetics, and., Takeda DY; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Kissick HT; Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA., Pinto PA; Urologic Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Choyke PL; Molecular Imaging Branch., Turkbey B; Molecular Imaging Branch., Dahut WL; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Karzai F; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Sowalsky AG; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.
Source: The Journal of clinical investigation [J Clin Invest] 2025 Sep 04; Vol. 135 (22). Date of Electronic Publication: 2025 Sep 04 (Print Publication: 2025).
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: eCollection Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40906535
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wilkinson+S%22">Wilkinson S</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Ku+AT%22">Ku AT</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Lis+RT%22">Lis RT</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22King+IM%22">King IM</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Low+D%22">Low D</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Trostel+SY%22">Trostel SY</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Bright+JR%22">Bright JR</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Terrigino+NT%22">Terrigino NT</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Baj+A%22">Baj A</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Summerbell+ER%22">Summerbell ER</searchLink>; Office of Intramural Research, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Heyward+KE%22">Heyward KE</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Kartal+S%22">Kartal S</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.; Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Fenimore+JM%22">Fenimore JM</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Li+C%22">Li C</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Singler+C%22">Singler C</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Vo+B%22">Vo B</searchLink>; Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Jansen+CS%22">Jansen CS</searchLink>; Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Ye+H%22">Ye H</searchLink>; Department of Pathology and Department of Urology, UCLA, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Whitlock+NC%22">Whitlock NC</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Harmon+SA%22">Harmon SA</searchLink>; Molecular Imaging Branch.<br /><searchLink fieldCode="AU" term="%22Carrabba+NV%22">Carrabba NV</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Atway+R%22">Atway R</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Lake+R%22">Lake R</searchLink>; Laboratory of Cancer Biology and Genetics, and.<br /><searchLink fieldCode="AU" term="%22Takeda+DY%22">Takeda DY</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Kissick+HT%22">Kissick HT</searchLink>; Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Pinto+PA%22">Pinto PA</searchLink>; Urologic Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Choyke+PL%22">Choyke PL</searchLink>; Molecular Imaging Branch.<br /><searchLink fieldCode="AU" term="%22Turkbey+B%22">Turkbey B</searchLink>; Molecular Imaging Branch.<br /><searchLink fieldCode="AU" term="%22Dahut+WL%22">Dahut WL</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Karzai+F%22">Karzai F</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Sowalsky+AG%22">Sowalsky AG</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2025 Sep 04; Vol. 135 (22). <i>Date of Electronic Publication: </i>2025 Sep 04 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40906535
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1172/JCI189900
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wilkinson S
      – PersonEntity:
          Name:
            NameFull: Ku AT
      – PersonEntity:
          Name:
            NameFull: Lis RT
      – PersonEntity:
          Name:
            NameFull: King IM
      – PersonEntity:
          Name:
            NameFull: Low D
      – PersonEntity:
          Name:
            NameFull: Trostel SY
      – PersonEntity:
          Name:
            NameFull: Bright JR
      – PersonEntity:
          Name:
            NameFull: Terrigino NT
      – PersonEntity:
          Name:
            NameFull: Baj A
      – PersonEntity:
          Name:
            NameFull: Summerbell ER
      – PersonEntity:
          Name:
            NameFull: Heyward KE
      – PersonEntity:
          Name:
            NameFull: Kartal S
      – PersonEntity:
          Name:
            NameFull: Fenimore JM
      – PersonEntity:
          Name:
            NameFull: Li C
      – PersonEntity:
          Name:
            NameFull: Singler C
      – PersonEntity:
          Name:
            NameFull: Vo B
      – PersonEntity:
          Name:
            NameFull: Jansen CS
      – PersonEntity:
          Name:
            NameFull: Ye H
      – PersonEntity:
          Name:
            NameFull: Whitlock NC
      – PersonEntity:
          Name:
            NameFull: Harmon SA
      – PersonEntity:
          Name:
            NameFull: Carrabba NV
      – PersonEntity:
          Name:
            NameFull: Atway R
      – PersonEntity:
          Name:
            NameFull: Lake R
      – PersonEntity:
          Name:
            NameFull: Takeda DY
      – PersonEntity:
          Name:
            NameFull: Kissick HT
      – PersonEntity:
          Name:
            NameFull: Pinto PA
      – PersonEntity:
          Name:
            NameFull: Choyke PL
      – PersonEntity:
          Name:
            NameFull: Turkbey B
      – PersonEntity:
          Name:
            NameFull: Dahut WL
      – PersonEntity:
          Name:
            NameFull: Karzai F
      – PersonEntity:
          Name:
            NameFull: Sowalsky AG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 09
              Text: 2025 Sep 04
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1558-8238
          Numbering:
            – Type: volume
              Value: 135
            – Type: issue
              Value: 22
          Titles:
            – TitleFull: The Journal of clinical investigation
              Type: main
ResultId 1